Dr. Avi Dor, a health economist, is a Professor in the Department of Health Policy and Management at the Milken Institute School of Public Health, George Washington University (GWU), and Director of its Health Economics and Health Policy PhD Programs. Having joined GWU in 2007, He previously served as the Mannix Medical Mutual Professor of Health Finance, at the Weatherhead School of Management, Case Western Reserve University, Research Fellow at the U.S. Agency for Health Care Policy and Research, currently known as AHRQ, and Research Associate at the Urban Institute. He is highly experienced in large data base analysis and econometric modeling of health care costs and outcomes, pharmaceutical pricing, and well as cost-effectiveness and return-on-investment analyses applied to health care settings. The recipient of numerous NIH award, he is currently PI of a large multi-site R01 award investigating determinants of hospital pricing. His research has been published in leading economics journals (e.g., American Economic Review, European Economic Review), leading field journals (e.g., Journal of Health Economics, Journal of Regulatory Economics, JEMS), medical journals (e.g., NEJM, JAMA, Cancer), major health policy journals (Health Affairs, Health Services Research, Inquiry). His teaches graduate health care economics courses at the Masters and PhD levels, and has supervised numerous doctoral level dissertations.
Avi Dor has consulted for a variety of organizations, including the World Bank, Amgen, GlaxoSmithKline, and Teva Pharmaceuticals, and patient advocacy organizations. In addition, he frequently serves on NIH and AHRQ grant review panels. His work has been cited by major media and trade press outlets including the New York Times, CNN, NPR, US News and World Report, Modern Healthcare, and Kaiser Health News. Dr. Dor’s other affiliation include the National Bureau of Economic Research (NBER), and a joint faculty appointments at the GWU Trachtenberg School of Public Policy.